Showing results (71-80 of 422) with videos related to
Sort By:
Pageof 43
Cancer|January 5, 2026
Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasmMarina Konopleva, Naveen Pemmaraju, Kendra L Sweet, et al.Transplantation and Cellular Therapy|October 25, 2022
Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task ForceSumithira Vasu, Shernan G Holtan, Akiko Shimamura, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2013
FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcomeShun He, Jianhong Chu, Sumithira Vasu, et al.Cancers|January 10, 2026
Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation TrialShivani Handa, Kristin Koenig, Qiuhong Zhao, et al.Blood|March 25, 2006
Tumor growth impedes natural-killer-cell maturation in the bone marrowJohn O Richards, Xing Chang, Bradley W Blaser, et al.Blood|January 17, 2013
Inhibition of the receptor tyrosine kinase Axl impedes activation of the FLT3 internal tandem duplication in human acute myeloid leukemia: implications for Axl as a potential therapeutic targetIl-Kyoo Park, Anjali Mishra, Jason Chandler, et al.Blood|October 9, 2008
The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell developmentIl-Kyoo Park, Chiara Giovenzana, Tiffany L Hughes, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Responsiveness of naive CD4 T cells to polarizing cytokine determines the ratio of Th1 and Th2 cell differentiationNatallia Mikhalkevich, Brian Becknell, Michael A Caligiuri, et al.Cell and Tissue Research|September 27, 2003
Characterization of leukemia-associated Rho guanine nucleotide exchange factor (LARG) expression during murine developmentBrian Becknell, Tiansheng Shen, Eman Maghraby, et al.Nature Immunology|August 18, 2025
Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacySai Xiao, Songqi Duan, Yaqun Hong, et al.Pageof 43